Anti-psychotics adherence among out-patients with schizophrenia in Hong Kong (original) (raw)

Attitudes Toward Antipsychotic Medication

David Healy

Archives of General Psychiatry, 2005

View PDFchevron_right

Treatment Patterns and Antipsychotic Medication Adherence Among Commercially Insured Patients With Schizoaffective Disorder in the United States

Erik Muser

Journal of Clinical Psychopharmacology, 2016

View PDFchevron_right

Cognitive Functions and Medication Compliance in relation to Quality of Life in Persons with Schizophrenia

Manoj K U M A R Bajaj

International Journal of Indian Psychology, 2018

View PDFchevron_right

Mental health prevalence and pathways to care

Miranda Van Hooff

2018

View PDFchevron_right

Mental Illness and Psychiatric Treatment Among Women

Walter R Gove

Psychology of Women Quarterly, 1980

View PDFchevron_right

Non-adherence with psychotropic medications in the general population

Andrew Bulloch

Social Psychiatry and Psychiatric Epidemiology, 2010

View PDFchevron_right

Patient and family attitudes toward schizophrenia treatment

Steven Siegel

Current Psychiatry Reports, 2004

View PDFchevron_right

Adherence, healthcare resource utilization and Medicaid spending associated with once-monthly paliperidone palmitate versus oral atypical antipsychotic treatment among adults recently diagnosed with schizophrenia

Erik Muser

BMC Psychiatry, 2017

View PDFchevron_right

Rational Polypharmacy in Psychiatry

Sai Krishna Tikka

Evidence-based Strategies in Herbal Medicine, Psychiatric Disorders and Emergency Medicine, 2015

View PDFchevron_right

The guideline “consultation psychiatry” of the Netherlands Psychiatric Association

Titus Van Os

Journal of Psychosomatic Research, 2009

View PDFchevron_right

Effect of Antipsychotic Withdrawal on Negative Symptoms in Schizophrenia

Stephan Arndt

Neuropsychopharmacology, 1994

View PDFchevron_right

Treatment, Adherence, and Disability in Bipolar Disorder

Petri Arvilommi

2016

View PDFchevron_right

Healthcare providers’ attitudes toward persons with schizophrenia

Dinesh Mittal

Psychiatric Rehabilitation Journal, 2014

View PDFchevron_right

Do Indian patients with schizophrenia need half the recommended clozapine dose to achieve therapeutic serum level? An exploratory study

Satish Suhas

Schizophrenia Research, 2020

View PDFchevron_right

Systematic review of patient and nurse attitudes to depot antipsychotic medication

Kevin Gournay

British Journal of Psychiatry, 2001

View PDFchevron_right

Treatment burden, not health risk attitude associated with adherence in patients with mental illness in South India

Dushad Ram

2023

View PDFchevron_right

Choice of antipsychotic treatment by European psychiatry trainees: are decisions based on evidence?

Nele Vriendt

BMC Psychiatry, 2012

View PDFchevron_right

Adherence to Clinic Appointments and Medication Among Patients Accessing Mental Health Clinics in Lilongwe, Malawi

Paul Mekani

Research Square (Research Square), 2024

View PDFchevron_right

Psychotic symptoms in patients with medical disorders

Rajnish Mago

Current Psychiatry Reports, 2004

View PDFchevron_right

Use of second-generation antipsychotics in the acute inpatient management of schizophrenia in the Middle East

Nasser Al Zain

Neuropsychiatric Disease and Treatment, 2015

View PDFchevron_right

Personality and Psychotic Disorders

Joan Jobsis

International Handbook of Clinical Hypnosis

View PDFchevron_right

The Mental Health Treatment Study

Gary Bond

Psychiatric Rehabilitation Journal, 2008

View PDFchevron_right

Attitudes Concerning Antipsychotic Depot Medication in the German General Population

Kai Kahl

Journal of Clinical Psychopharmacology, 2018

View PDFchevron_right

Homeopathy and Mental Health

Balaji Deekshitulu P V

International journal of traditional and complementary medicine, 2016

View PDFchevron_right

Review of psychotherapeutic interventions for people with schizophrenia

Lluís Lalucat i Jo

View PDFchevron_right